54 related articles for article (PubMed ID: 32099332)
1. New Isatin-Indole Conjugates: Synthesis, Characterization, and a Plausible Mechanism of Their in vitro Antiproliferative Activity.
Al-Wabli RI; Almomen AA; Almutairi MS; Keeton AB; Piazza GA; Attia MI
Drug Des Devel Ther; 2020; 14():483-495. PubMed ID: 32099332
[TBL] [Abstract][Full Text] [Related]
2. Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer.
Eldehna WM; Salem R; Elsayed ZM; Al-Warhi T; Knany HR; Ayyad RR; Traiki TB; Abdulla MH; Ahmad R; Abdel-Aziz HA; El-Haggar R
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1424-1435. PubMed ID: 34176414
[TBL] [Abstract][Full Text] [Related]
3. New hydrazonoindolin-2-ones: Synthesis, exploration of the possible anti-proliferative mechanism of action and encapsulation into PLGA microspheres.
Attia MI; Eldehna WM; Afifi SA; Keeton AB; Piazza GA; Abdel-Aziz HA
PLoS One; 2017; 12(7):e0181241. PubMed ID: 28742842
[TBL] [Abstract][Full Text] [Related]
4. Thiazolyl-isatin derivatives: Synthesis, in silico studies, in vitro biological profile against breast cancer cells, mRNA expression, P-gp modulation, and interactions of Akt2 and VIM proteins.
Freitas LAB; Sousa C; Lima BS; Duarte D; Gomes PATM; Ramos CGC; Costa VCM; Pitta MGDR; Rêgo MJBM; de Simone CA; Videira M; Leite ACL
Chem Biol Interact; 2024 May; 394():110954. PubMed ID: 38518852
[TBL] [Abstract][Full Text] [Related]
5. Synthesis biological evaluation and molecular docking of isatin hybrids as anti-cancer and anti-microbial agents.
Altamimi M; Syed SA; Tuzun B; Alhazani MR; Alnemer O; Bari A
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2288548. PubMed ID: 38073431
[TBL] [Abstract][Full Text] [Related]
6. A Series of Isatin-Hydrazones with Cytotoxic Activity and CDK2 Kinase Inhibitory Activity: A Potential Type II ATP Competitive Inhibitor.
Al-Salem HS; Arifuzzaman M; Alkahtani HM; Abdalla AN; Issa IS; Alqathama A; Albalawi FS; Rahman AFMM
Molecules; 2020 Sep; 25(19):. PubMed ID: 32992673
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of model cyclopentene-[
El-Abadelah MM; Abdullah AH; Zahra JA; Sabri SS; Bardaweel SK; Taha MO
Z Naturforsch C J Biosci; 2024 Jan; 79(1-2):41-46. PubMed ID: 38414412
[TBL] [Abstract][Full Text] [Related]
8. Investigations on Anticancer Potentials by DNA Binding and Cytotoxicity Studies for Newly Synthesized and Characterized Imidazolidine and Thiazolidine-Based Isatin Derivatives.
Arshad N; Mir MI; Perveen F; Javed A; Javaid M; Saeed A; Channar PA; Farooqi SI; Alkahtani S; Anwar J
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056668
[TBL] [Abstract][Full Text] [Related]
9. Novel mitochondrial and DNA damaging fluorescent Calix[4]arenes bearing isatin groups as aromatase inhibitors: Design, synthesis and anticancer activity.
Oguz A; Saglik BN; Oguz M; Ozturk B; Yilmaz M
Bioorg Med Chem; 2024 Jan; 98():117586. PubMed ID: 38171252
[TBL] [Abstract][Full Text] [Related]
10. The anti-breast cancer potential of indole/isatin hybrids.
Wang R; Huang R; Yuan Y; Wang Z; Shen K
Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300402. PubMed ID: 37650315
[TBL] [Abstract][Full Text] [Related]
11. Identification of a new bisindolinone arresting IGROV1 cells proliferation.
Morigi R; Zalambani C; Farruggia G; Verardi L; Esposito D; Leoni A; Borsetti F; Voltattorni M; Zambonin L; Pincigher L; Calonghi N; Locatelli A
Eur J Med Chem; 2024 May; 271():116365. PubMed ID: 38640869
[TBL] [Abstract][Full Text] [Related]
12. Early pharmacological profiling of isatin derivatives as potent and selective cytotoxic agents.
Puerta A; González-Bakker A; Brandão P; Pineiro M; Burke AJ; Giovannetti E; Fernandes MX; Padrón JM
Biochem Pharmacol; 2024 Apr; 222():116059. PubMed ID: 38364984
[TBL] [Abstract][Full Text] [Related]
13. Expansion of a Synthesized Library of N-Benzyl Sulfonamides Derived from an Indole Core to Target Pancreatic Cancer.
Hopkins MD; Costello IJ; Brandeburg ZC; Slay EL; Zanders LA; Dunn CE; Derewonko CA; Davitt CL; Reeder MA; Prichard K; Chiew B; McCluskey A; Sheaff RJ; Lamar AA
ChemMedChem; 2023 Oct; 18(19):e202300265. PubMed ID: 37421174
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel spirochromane incorporating Schiff's bases, potential antiproliferative activity, and dual EGFR/HER2 inhibition: Cell cycle analysis and
Othman DIA; Hamdi A; Elhusseiny WM; El-Azab AS; Bakheit AH; Hefnawy M; Abdel-Aziz AA
Saudi Pharm J; 2023 Nov; 31(11):101803. PubMed ID: 37860686
[TBL] [Abstract][Full Text] [Related]
15. Isatin-indoloquinoxaline click adducts with a potential to overcome platinum-based drug-resistance in ovarian cancer.
Chowdhary S; Raza A; Preeti ; Kaur S; Anand A; Sharma AK; Kumar V
Bioorg Chem; 2024 Jan; 142():106953. PubMed ID: 37925887
[TBL] [Abstract][Full Text] [Related]
16. Novel hydrazone-isatin derivatives as potential EGFR inhibitors: Synthesis and in vitro pharmacological profiling.
Ahmed MF; El-Haggar R; Almalki AH; Abdullah O; El Hassab MA; Masurier N; Hammad SF
Arch Pharm (Weinheim); 2023 Sep; 356(9):e2300244. PubMed ID: 37404064
[TBL] [Abstract][Full Text] [Related]
17. Marine compounds selectively induce apoptosis in female reproductive cancer cells but not in primary-derived human reproductive granulosa cells.
Edwards V; Benkendorff K; Young F
Mar Drugs; 2012 Jan; 10(1):64-83. PubMed ID: 22363221
[TBL] [Abstract][Full Text] [Related]
18. Microwave-induced one-pot synthesis of 3-imidazolyl indole clubbed 1,2,3-triazole hybrids as antiproliferative agents and density functional theory study.
Chudasama DD; Rajput CV; Patel MS; Parekh JN; Patel HC; Chikhaliya NP; Puerta A; Padrón JM; Ram KR
Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300632. PubMed ID: 38150663
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological activity evaluation and mechanism of action of novel bis-isatin derivatives as potential anti-liver cancer agents.
Li Z; Ma J; Tian M; Xia P; Lv X; Hou R; Jiang Y; Xu X; Jia Z; Wang J; Li Z
Bioorg Med Chem Lett; 2024 Feb; 99():129613. PubMed ID: 38224754
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Drug-Likeness Evaluation of Some Heterocyclic Moieties Fused Indole Derivatives as Potential Antioxidants.
Kumari A; Singh RK
Comb Chem High Throughput Screen; 2023; 26(11):2077-2084. PubMed ID: 36593539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
